DongKook Pharmaceutical Co., Ltd. (086450.KQ) KOE

Currency In KRW

AD

Valuation

Market Cap761.43B
Enterprise Value781.49B
P/E Ratio10.57
PEG Ratio0.39
Price/Sales Ratio0.83
Price/Book Ratio1.17
Enterprise/Revenue0.84
Enterprise/EBITDA6.14

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.08
Operating Margin0.1
AD

Management Effectiveness

Return On Assets0.07
Return On Equity0.11

Income Statement

Revenue926.88B
Revenue/Share21,151.47
Gross Profit501.6B
EBITDA127.97B
Net Income66.02B
Diluted EPS1,475

Balance Sheet

Total Cash118.36B
Total Cash/Share2,623.77
Total Debt67.98B
Total Debt/Equity0.1
Current Ratio2.06
Book Value Per Share17,326.78

Price History

52-Week Change0
52-Week High31,250
52-Week Low16,260
Moving Average 50 Days22,213
Moving Average 200 Days19,658.05

Statistics

Average Volume694,050
Shares Outstanding45.11M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate200
Trailing Annual Dividend Yield1.14
Payout Ratio0.12
Last Split Factor5:1
Last Split DateAugust 24, 2020
AD